Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
81M
-
Shares change
-
+8.09M
-
Total reported value, excl. options
-
$1.51B
-
Value change
-
+$147M
-
Put/Call ratio
-
0.05
-
Number of buys
-
155
-
Number of sells
-
-109
-
Price
-
$18.64
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2025
325 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q2 2025.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 269 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81M shares
.
Largest 10 shareholders include BlackRock, Inc. (10.9M shares), VANGUARD GROUP INC (7.37M shares), Sessa Capital IM, L.P. (5M shares), GW&K Investment Management, LLC (2.89M shares), ArrowMark Colorado Holdings LLC (2.7M shares), STATE STREET CORP (2.65M shares), Hood River Capital Management LLC (2.56M shares), GOLDMAN SACHS GROUP INC (1.89M shares), Paradice Investment Management LLC (1.77M shares), and Stephens Investment Management Group LLC (1.74M shares).
This table shows the top 269 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.